Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations

Here we describe the successful use of intravenous immunoglobulin (IVIG) in the management of mycoplasma-induced, atypical Stevens-Johnson syndrome (SJS) with minimal skin manifestations. The patient was successfully managed with high-dose IVIG 0.5 g/kg for 4 consecutive days. No complications were...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pediatrics 2007-06, Vol.166 (6), p.585-588
Hauptverfasser:	ZIPITIS, Christos S, THALANGE, Nandu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Biological and medical sciences Bullous diseases of the skin Dermatology Diagnosis, Differential General aspects Humans Immunoglobulins, Intravenous - therapeutic use Male Medical sciences Mycoplasma pneumoniae - isolation & purification Mycoplasma pneumoniae - pathogenicity Stevens-Johnson Syndrome - diagnosis Stevens-Johnson Syndrome - drug therapy Stevens-Johnson Syndrome - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Here we describe the successful use of intravenous immunoglobulin (IVIG) in the management of mycoplasma-induced, atypical Stevens-Johnson syndrome (SJS) with minimal skin manifestations. The patient was successfully managed with high-dose IVIG 0.5 g/kg for 4 consecutive days. No complications were noted. IVIG may be useful in the management of mycoplasma-induced SJS.
ISSN:	0340-6199 1432-1076
DOI:	10.1007/s00431-006-0287-9